Dasatinib Tablets

2000 INR

Get a Price/Quote

Product Details:

Drug Type Specific Drug
Physical Form Tablets
Dosage 70 mg
Suitable For Adults, Women
Supply Ability : 10000000 Piece Per Week
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Price And Quantity

Minimum Order Quantity 10000000 Piece
Price 2000 INR

Product Specifications

Dosage 70 mg
Drug Type Specific Drug
Physical Form Tablets
Suitable For Adults, Women

Trade Information

Payment Terms Cash in Advance (CID), Cash Advance (CA)
Supply Ability 10000000 Piece Per Week
Delivery Time 1 Week
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

Dasatinib Tablets

We are engaged in the wholesale, supply, and export of hygienically processed Dasatinib Sprycel used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other cancer treatments have not been effective. It slows the growth and spread of cancer cells in the body and blocks the action of abnormal proteins that signals the cancer cells to multiply.

Dasatinib, previously known as BMS-354825, is a cancer drug produced by Bristol-Myers Squibb and sold under the trade name Sprycel.

Features: